{"schema_version":"secwatch.filing_event.v1","accession":"0001653477-22-000038","form_type":"8-K","ticker":"NGVT","cik":"0001653477","company_name":"Ingevity Corp","filed_at":"2022-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.589860+00:00","generated_at":"2026-06-22T14:21:10.664617+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Ingevity reports record Q3 sales $482M, adjusted EBITDA $138M; raises FY22 guidance","bullets":["Record sales of $482.0M, up 27.9% YoY; net income $75.4M, diluted EPS $1.98, adjusted EPS $2.09.","Record adjusted EBITDA of $138.2M, up 15.6%; margin 28.7%. Operating cash flow $100.1M, free cash flow $64.0M.","Share repurchases of $49.3M in Q3, $139.2M YTD.","Completed acquisition of Ozark Materials on Oct 3; no deal value disclosed.","Raises FY2022 sales guidance to $1.65B-$1.70B, adjusted EBITDA to $460M-$475M."],"urls":{"canonical":"https://secwatch.observer/filing/0001653477-22-000038","json":"https://secwatch.observer/filing/0001653477-22-000038.json","markdown":"https://secwatch.observer/filing/0001653477-22-000038.md","text":"https://secwatch.observer/filing/0001653477-22-000038.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1653477/000165347722000038/0001653477-22-000038-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1653477/000165347722000038/ngvt-20221102.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T14:21:10.664617+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"84a0dc5b9a3dfc3d71b27cbf9f7c58b157b79f17","claim":"Ingevity Corp reported the three months ended September 30, 2022 results: revenue $482.0 million, net income $75.4 million, EPS $1.98. Guidance raised.","evidence_excerpt":"Ingevity reports third quarter 2022 financial results HIGHLIGHTS : (comparisons versus prior year period) • Company delivered record sales of $482.0 million, up 27.9% • Net income of $75.4 million and diluted earnings per share (EPS) of $1.98;","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1653477/000165347722000038/0001653477-22-000038-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended September 30, 2022"},{"label":"Revenue","value":"$482.0 million"},{"label":"Net income","value":"$75.4 million"},{"label":"EPS","value":"$1.98"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"ec3db5eaf1129e481ddf957182a98a212fcf4494","claim":"Ingevity Corp reported full year 2022 results: revenue between $1.65 billion and $1.70 billion. Guidance raised.","evidence_excerpt":"Company raises full year 2022 sales guidance to between $1.65 billion and $1.70 billion and adjusted EBITDA to between $460 million and $475 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1653477/000165347722000038/0001653477-22-000038-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year 2022"},{"label":"Revenue","value":"between $1.65 billion and $1.70 billion"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}